References
- HengelRLWattsNBLennoxJLBenign symmetric lipomatosis associated with protease inhibitorsLancet199735015969393341
- GargAAcquired and inherited lipodystrophiesN Engl J Med20043501220123415028826
- OetteMJuretzkoPKroidiALipodistrophy syndrome and self-assessment of well being and physical appearance in HIV-positive patientsAIDS Patient Care STDS20021641341712396693
- KotlerDPRosenbaumKWangJPiersonRNStudies of body composition and fat distribution in HIV-infected and control subjectsJ Acquir Immune Defic Syndr Hum Retrovirol1999353917020932099
- LundgrenJDBattegayMBehrensGEuropean AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVHIV Med20089728118257770
- SutinenJInterventions for managing antiretroviral therapy-associated lipoatrophyCurr Opin Infect Dis2005181253315647696
- MallewaJEWilkinsEVilarJHIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic optionsJ Antimicrob Chemother200862464866018565973
- CohenGTreherneATreatment of facial lipoatrophy via autologous fat transferJ Drugs Dermatol20098548648919537373
- Aquamid® (Injectable polyacrilamide gel) Prescribing information. 28 July 2005. Contura International; Soeberg, Denmark. Available from: http://www.aquamid.com/Web/Aquamid/Professional/Professional//What+are+aquamid+injectable+implants.
- Sculptra® (Iniectable poly-L-Lactic acid) Prescribing information82004Dermik LaboratoriesBerwin PA, USA Available from: http://www1.sculptra.com/US/hcp/PI.jsp.
- NarcisoPBucciardiniRTozziVKImmediate versus delayed surgical intervention for reconstructive therapy of HIV associated facial lipoatrophy. A randomized open label studyAIDS Res Hum Retroviruses2009251097998719795984
- AscherBColemanSAlsterTFull scope of effect of facial lipoatrophy: a framework of disease understandingDermatol Surg2006321058106916918569
- CarrALawMAn objective lipodystrophy severity grading scale derived from the lipodystrophy case definition scoreJ Acquir Immune Defic Syndr20033357112902800
- Von BuelowSPalluaNEfficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patientsPlast Reconstr Surg200611885S91S16936548
- MoyleGJLysakovaLBrownSA randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infectionHIV Med20045828715012646
- HuangSJBecerraKFernandezSLeeDMatthewsWCThe impact of HIV-associated lipodistrophy on healthcare utilization and costsAids Res Ther200851418593479
- CareyDLiewSEmerySRestorative interventions for HIV facial lipoatrophyAIDS Rev20081011612418615122
- LemperleGMorhennVCharrierUHuman histology and persistence of various injectable filler substances for soft tissue augmentationAesthetic Plast Surg20032735436614648064
- GuaraldiGOrlandoGDe FazioDComparison of three diffrent interventions for correction of HIV-associated facial lipoatrophy: a prospective studyAntiviral Ther200510753759